Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have captured the first detailed molecular ...

This article explores how challenges such as sequence optimization, immune activation and off-target effects are being ...

The Scottish technology firm has raised a second tranche of investment to further grow its business in the field of early disease detection ...

Sanofi’s Qfitlia and Cablivi approved in China, expanding care for rare diseasesQfitlia, the first antithrombin-lowering therapy for hemophilia, ...

“The opportunity to deploy our diagnostic platform globally through our partner laboratories is taking shape” – Eve Hanks, chief executive and founder ...

The test is now ordered by breast surgeons or radiation oncologists in more than 85% of the top 50 U.S. cancer centers.

This second venture capital (VC) led financing follows a $4m Series A raise last year and involved existing investors ...

CEATEC 2025 featured the usual lineup of AI demos, service robots, and experimental interfaces. But inside Hall 4, a quieter, lab-style booth ...

Stanford Medicine investigators have unearthed the biological process by which mRNA-based vaccines for COVID-19 can cause ...

Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...

Company addresses FDA requests regarding formulation excipient – Global site start-up activities continue, with first-patient-in for ...